Heron Therapeutics

HRTX · NASDAQ

$0.3545−$0.0064 (−1.77%)TodayMarket closed ·
Prev close $0.3609

Who owns HRTX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 48.9% of HRTX’s shares.

  • Rubric Capital Management LP15.9%
  • Clearline Capital LP6.0%
  • BlackRock Institutional Trust Company, N.A.5.1%
  • Velan Capital Investment Management LP4.6%
  • Next 6 largest institutions17.2%
  • All other shareholders51.1%
Top institutional holders of HRTX
HolderShares% of shares
Rubric Capital Management LP30.05M15.87%
Clearline Capital LP11.38M6.01%
BlackRock Institutional Trust Company, N.A.9.71M5.13%
Velan Capital Investment Management LP8.75M4.62%
Vanguard Capital Management, LLC7.78M4.11%
Tejara Capital Ltd.6.51M3.44%
Tang Capital Management, LLC6.25M3.30%
Geode Capital Management, L.L.C.4.27M2.26%
Millennium Management LLC4.07M2.15%
JW Asset Management, LLC3.75M1.98%

Largest mutual fund holders

Top mutual fund holders of HRTX
HolderShares% of shares
Vanguard Total Stock Market Index Fund5.47M2.89%
iShares Russell 2000 ETF3.67M1.94%
Biotech Growth Trust PLC2.92M1.54%
Vanguard Extended Market Index Fund2.10M1.11%
Fidelity Small Cap Index Fund1.63M0.86%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of HRTX in the last 6 months.

Latest HRTX insider transactions
InsiderTypeSharesValue
Hensley Mark EarlOption exercise31.25K—
Hensley Mark EarlTax withholding8.89K$4.44K
Hensley Mark EarlOption exercise31.25K—
Hensley Mark EarlOption exercise11.77K—
Hensley Mark EarlOption exercise11.77K—
Duarte IraOption exercise11.69K—
Duarte IraTax withholding3.33K$1.66K
Duarte IraOption exercise11.69K—
Collard Craig AOption exercise34.79K—
Collard Craig AOption exercise34.79K—

Short interest

Settled Sep 30, 2026

Shares short
46.02M
Days to cover
17.30
% of shares outstanding
24.31%
Average daily volume
2.66M
Change since last report
+6.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.